Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats

Diabetes mellitus (DM) has significant effects on cardiac calcium (Ca(2+)) and sodium (Na(+)) regulation. Clinical studies have shown that empagliflozin (Jardiance™) has cardiovascular benefits, however the mechanisms have not been fully elucidated. This study aimed to investigate whether empagliflo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ting-I, Chen, Yao-Chang, Lin, Yung-Kuo, Chung, Cheng-Chih, Lu, Yen-Yu, Kao, Yu-Hsun, Chen, Yi-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479313/
https://www.ncbi.nlm.nih.gov/pubmed/30987285
http://dx.doi.org/10.3390/ijms20071680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479313/
https://www.ncbi.nlm.nih.gov/pubmed/30987285
http://dx.doi.org/10.3390/ijms20071680

Ejemplares similares